Treatment Updates in RCC

ASCO GU 2023 Conference Coverage
M

ASCO GU 2023 3-Year Follow-Up From The Phase 3 CheckMate 9ER Trial: Nivolumab + Cabozantinib vs. Sunitinib for 1L Treatment of Advanced RCC

By ASCO GU 2023 Conference Coverage FEATURING Mauricio Burotto
By ASCO GU 2023 Conference Coverage FEATURING Mauricio Burotto
369 views
February 21, 2023
Comments 0
Login to view comments. Click here to Login
08:35

Patient-Reported Outcomes of Patients With Advanced RCC Treated With…

Northwestern Medicine Oncology and Hematology

D. Cella

260 views
10:22

Clinical Implications of CheckMate 9ER Data: Applications for Practi…

Rush University Medical Center

A. Tan

466 views
22:44

ASCO® 2023 Summary: "RCC Updates From The Recent Trials"

Dana-Farber Cancer Institute

W. Xu, T. Choueiri

240 views
17:48

ASCO® 2023 Insights: "Combination Therapies Come of Age in Kidney Ca…

Insights from 2023 ASCO® Annual Meeting

D. Braun

50 views
03:49

ASCO® 2023 Insights: "HR-QoL Measures in RCC - Patient-Reported Rele…

Insights from 2023 ASCO® Annual Meeting

C. Decat Bergerot

31 views
09:59

ASCO® 2023 Insights: "When to Play the Systemic Therapy Card in Olig…

Insights from 2023 ASCO® Annual Meeting

K. Runcie

145 views
23:16

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients With…

Insights from 2023 ASCO® Annual Meeting

B. McGregor

454 views
07:12

ASCO® 2023 Insights: "Association of Host Immune Signatures With Res…

Insights from 2023 ASCO® Annual Meeting

E. Saad

89 views
17:19

Optimal Toxicity Management in mRCC

Kate Young

141 views
20:18

Dana-Farber Cancer Institute Kidney Cancer Updates From ASCO GU 2023

Dana-Farber Cancer Institute

W. Xu, T. Choueiri

260 views
10:24

Front-Line Treatment of Renal Cell Carcinoma

Benjamin Garmezy

424 views
15:44

How to Select Frontline Therapy for Metastatic Clear Cell RCC

Matthew Campbell

577 views
09:12

ASCO GU 2023 Longitudinal Detection of ctDNA in Patients With Advanc…

ASCO GU 2023 Conference Coverage

A. Basu, C. Park

249 views